The Pre-Commercial Procurement (PCP) project OncNGS has entered its final phase with two cutting-edge solutions for Next-Generation Sequencing (NGS) cancer tests. The Call-off for Phase[…]

On the 14, 20 and 26 March 2024, the monitoring team of the oncNGS consortium conducted three site visits on the premises (laboratory) of the[…]

The Call-off for Phase 2 was launched in early July 2023 where four successful suppliers from Phase 1 were invited to submit an offer.  […]

The eight procurers of the oncNGS consortium, representing healthcare providers from Belgium, Italy, France, Spain and Germany, selected four novel approaches for NGS cancer tests,[…]

The oncNGS consortium is delighted to announce that our oncNGS PCP call for tender is now open for submission at TED (Tenders Electronic Daily), the[…]

Before the launch of the new oncNGS pre-commercial procurement call for tenders, the oncNGS consortium organised a Suppliers Information Day on the 29th June 2022.[…]

The OncNGS consortium launched a Call for Tender in December 2021. Due to some unforeseen circumstances, the current Tender procedure is closed and a new Call[…]

OncNGS partners took the advantage of the improvement of the COVID situation across Europe to have two face to face meetings, one in Barcelona and[…]

Please find below the last updates of the oncNGS PCP Call for tender process: The deadline to answer the Call for Tender has been extended![…]